Prologue: Regulatory Considerations for Continuous Manufacturing

On Demand

Location:Online Only

Manufacturing and Analytical Characterization

Prologue Speaker(s)

Scott Krull, PhD (he/him/his)

Chemical Engineer
US Food and Drug Administration
Silver Spring, Maryland

This presentation highlights regulatory considerations, progress, and lessons learned regarding continuous pharmaceutical manufacturing.

To view all Prologues, visit our library here and click "Enroll".

Learning Objectives:

Gain an understanding of the concept and benefits of continuous pharmaceutical manufacturing.
Discover how regulators have taken action to remove perceived hurdles in submissions involving continuous manufacturing.
Explore ways regulators are engaging with stakeholders to support industry innovation.